Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The urokinase pulmonary embolism trial. A national cooperative study.

× No keyword cloud information.

29 in total

Review 1. Use of plasminogen activators in venous thrombosis.

Authors: J Hirsh; A G Turpie
Journal: World J Surg Date: 1990 Sep-Oct Impact factor: 3.352

2. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors: Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal: Chest Date: 2012-02 Impact factor: 9.410

Review 3. The value of electrocardiographic abnormalities in the prognosis of pulmonary embolism: a consensus paper.

Authors: Geneviève C Digby; Piotr Kukla; Zhong-Qun Zhan; Carlos A Pastore; Ryszard Piotrowicz; Edgardo Schapachnik; Wojciech Zareba; Antonio Bayés de Luna; Piotr Pruszczyk; Adrian M Baranchuk
Journal: Ann Noninvasive Electrocardiol Date: 2015-05 Impact factor: 1.468

Review 4. Fibrinolysis for Acute Care of Pulmonary Embolism in the Intermediate Risk Patient.

Authors: Guy Meyer; Benjamin Planquette; Olivier Sanchez
Journal: Curr Atheroscler Rep Date: 2015-12 Impact factor: 5.113

5. Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study.

Authors: Seth R Bauer; Narith N Ou; Benjamin J Dreesman; Jeffrey J Armon; Jan A Anderson; Stephen S Cha; Lance J Oyen
Journal: Mayo Clin Proc Date: 2009-12 Impact factor: 7.616

6. Pulmonary thromboembolism in children.

Authors: D J Matthew; M Levin
Journal: Intensive Care Med Date: 1986 Impact factor: 17.440

7. Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparin.

Authors: Carlos Jerjes-Sánchez; Sergio Villarreal-Umaña; Alicia Ramírez-Rivera; Anabel Garcia-Sosa; Luis Miguel-Canseco; Tamara Archondo; Esteban Reyes; Angel Garza; Roberto Arriaga; Francisco Castillo; Omar Jasso; Hector Garcia; Martha Bermudez; Jose Maria Hernandez; Jorge Garcia; Pedro Martinez; Francisco Rangel; Jorge Gutierrez; Alfredo Comparan-Nuñez
Journal: J Thromb Thrombolysis Date: 2008-01-19 Impact factor: 2.300

8. The rate of resolution of clot burden measured by pulmonary CT angiography in patients with acute pulmonary embolism.

Authors: Ayaz Aghayev; Alessandro Furlan; Amol Patil; Serter Gumus; Kyung Nyeo Jeon; Bumwoo Park; Kyongtae T Bae
Journal: AJR Am J Roentgenol Date: 2013-04 Impact factor: 3.959

9. Therapeutic approach to acute pulmonary embolism.

Authors: P Duroux; G Simonneau; P Petitpretz; P Herve
Journal: Intensive Care Med Date: 1984 Impact factor: 17.440

Review 10. Antithrombotic drugs: part I.

Authors: A S Gallus; J Hirsh
Journal: Drugs Date: 1976 Impact factor: 9.546